This episode of Diasorin’s Beyond the Result podcast features host Angelo Rago chatting with Mark Zaydman, MD, PhD, assistant professor of pathology and immunology in the Division of Laboratory and Genomic Medicine of Washington University in St. Louis.Highlights include: • The transition to value-based medicine will not be feasible without clearly defining value and determining how to measure it. Until then, the focus on value is often misinterpreted as cost-cutting without a clear patient benefit.• Establishing value in laboratory medicine requires a clear understanding of how a clinician will use test results — will they lead to a material change in patient care and, ultimately, patient outcomes? Or could those test results have been easily predicted from other clinical data points, in which case they offer little new value?• With so many stakeholders across healthcare and complex relationships among them, the best way to get alignment is by putting patients at the center and focusing on better outcomes as the primary goal.• Collaborations across stakeholders, including industry partners, will be essential for creating more personalized care for patients.Credits: Host – Angelo Rago, President of Luminex division of Diasorin Guest – Mark Zaydman, MD, PhD, assistant professor of pathology and immunology in the Division of Laboratory and Genomic Medicine of Washington University in St. LouisProducers – Stephanie Ibbotson, Sr. Director of Strategic Marketing and Market Access and Michelle Tabb, PhD, Chief Scientific Officer Editor – Britta Good, Graphic Designer, Global Marketing Sign up to be notified for new episodes: